Ingevity Corporation NGVT
At closeNov 6, 2026, 6:30 AM EST
Pre-market · Nov 6, 6:30 AM ET
- YTD
- +7.65%
- 1 year
- +16.98%
- Market cap
- 2.19B
- Revenue (ttm)
- 1.16B
- Profit margin
- 4.65%
- EPS (ttm)
- 1.05
- Shares out
- 34.38M
- P/E ratio
- 60.68
- Forward P/E
- 12.26
- YTD return
- +7.65%
- 1-year return
- +16.98%
- Volume
- 896.27K
- Avg volume
- 282.69K
- Open
- 67.99
- Previous close
- 73.73
- Day's range
- 61.67 – 69.30
- 52-week range
- 45.85 – 79.29
- Beta
- 1.11
- Analysts
- Strong Buy
- Price target
- 89.00 (+39.7%)
- Earnings date
- Feb 24, 2027
5D -11.67 (-15.48%)
Key statistics
- Enterprise value
- 3.67B
- PEG ratio
- 2.41
- Price / sales
- 2.18
- Price / book
- 54.21
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- -5.20%
- Free cash flow
- 88.94M
- Total cash
- 97.40M
- Total debt
- 1.24B
- Return on equity
- 30.07%
- Short % of float
- 5.60%
- 50-day average
- 70.59
- 200-day average
- 71.33
Analyst view
Consensus: strong buy
- Target (low)
- 85.00
- Target (mean)
- 89.00
- Target (high)
- 92.00
- Strong buy1
- Buy2
- Hold0
- Sell0
- Strong sell0
Next earnings
Feb 24, 2027
Expected Feb 24, 2027. Consensus EPS estimate 1.59.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 24, 2027 | Dec 30, 2026 | 0.90 | — | — | — |
| Nov 4, 2026 | Sep 30, 2026 | 1.56 | 1.63 | +0.07 | +4.49% |
| Jul 29, 2026 | Jun 30, 2026 | 1.33 | 1.74 | +0.41 | +30.83% |
| May 6, 2026 | Mar 31, 2026 | 0.84 | 1.15 | +0.31 | +36.90% |
| Feb 25, 2026 | Dec 31, 2025 | 0.665 | 0.58 | -0.09 | -12.78% |
| Nov 5, 2025 | Sep 30, 2025 | 0.68 | 1.31 | +0.63 | +92.65% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 27, 2026 | Wells Fargo | main | Equal-Weight | Equal-Weight |
| Jan 29, 2026 | Wells Fargo | main | Equal-Weight | Equal-Weight |
| Dec 19, 2025 | Wells Fargo | main | Equal-Weight | Equal-Weight |
| Dec 10, 2025 | BMO Capital | main | Outperform | Outperform |
| Nov 12, 2025 | Wells Fargo | main | Equal-Weight | Equal-Weight |
| Sep 5, 2025 | BMO Capital | main | Outperform | Outperform |
About Ingevity Corporation
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. This segment also produces other activated carbon products for food, water, beverage, and chemical purification applications. The Performance Chemicals segment consists of road technologies and industrial specialties. This segment's products are used in pavement construction, pavement preservation, pavement reconstruction and recycling, road markings, agrochemical dispersants, lubricants, certain adhesives, rubber, and other industrial uses. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. It serves automotive parts manufacturers through sales representatives, third-party sales representatives, and distributors. The company was formerly known as WestRock Company, Specialty Chemicals Business and changed its name to Ingevity Corporation in September 2015. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- Country
- United States
- Website
- ingevity.com
News
Ingevity Q3 2026 Earnings Call Transcript
Ingevity (NGVT) Surpasses Q3 Earnings and Revenue Estimates Ingevity Raises FY2026 Adj EPS Guidance from $5.00-$5.45 to $5.25-$5.45 vs $5.36 Est; Narrows FY2026 Sales Guidance from $1.050B-$1.150B to $1.100B vs $1.114B Est
Ingevity Q3 Adj. EPS $1.63 Beats $1.57 Estimate, Sales $305.100M Beat $304.600M Estimate
Ingevity reports third quarter 2026 financial results Ingevity Raises FY2026 Adj EPS Guidance from $4.70-$5.20 to $5.00-$5.45 vs $5.01 Est; Affirms FY2026 Sales Guidance of $1.050B-$1.150B vs $1.109B Est
Ingevity Q2 Adj. EPS $1.74 Beats $1.33 Estimate, Sales $314.100M Beat $312.200M Estimate
Ingevity’s Evotherm P35 Secures BASt Approval For Warm‑Mix Asphalt In Germany
Earnings Scheduled For May 6, 2026 Ingevity Widens FY2026 Adj EPS Guidance from $4.80-$5.20 to $4.70-$5.20 vs $4.80 Est; Lowers FY2026 Sales Guidance from $1.100B-$1.200B to $1.050B-$1.150B vs $1.187B Est
Your note
Sign in to keep a note on NGVT — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BLACKWELL JEAN S. | Director | Stock Award(Grant) | Apr 30, 2025 | 24,359 |
| FERNANDEZ MORENO LUIS M | Director | Stock Award(Grant) | Apr 29, 2026 | 37,882 |
| HALL MARY DEAN | Chief Financial Officer | Stock Award(Grant) | Feb 25, 2026 | 41,775 |
| LI DAVID H | Chief Executive Officer | Sale | Aug 17, 2026 | 120,544 |
| LYNCH FREDERICK J | Director | Stock Award(Grant) | Apr 29, 2026 | 28,263 |
| NARWOLD KAREN G | Director | Stock Award(Grant) | Apr 29, 2026 | 18,900 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 15.60% | 5,364,204 | 395.45M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 6.91% | 2,376,803 | 175.22M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.57% | 1,571,127 | 115.82M | Jun 29, 2026 |
| State Street Corporation | 4.36% | 1,497,321 | 110.38M | Jun 29, 2026 |
| American Century Companies Inc | 3.70% | 1,270,958 | 93.70M | Jun 29, 2026 |
| Wellington Management Group, LLP | 3.13% | 1,075,514 | 79.29M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.95% | 2,046,558 | 150.87M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.23% | 1,109,489 | 81.79M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.63% | 903,003 | 66.57M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.31% | 795,806 | 58.67M | Jun 29, 2026 |
| American Century Capital Portfolios, Inc.-Small Cap Value Fund | 1.93% | 665,000 | 49.02M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | 1.47% | 505,155 | 37.24M | Jun 29, 2026 |
